Seres Therapeutics (MCRB) Misses Q1 EPS by 28c
Seres Therapeutics (NASDAQ: MCRB) reported Q1 EPS of ($0.28). Revenue for the quarter came in at $360 thousand.
For earnings history and earnings-related data on Seres Therapeutics (MCRB) click here.
Seres Therapeutics (NASDAQ: MCRB) reported Q1 EPS of ($0.28). Revenue for the quarter came in at $360 thousand.
For earnings history and earnings-related data on Seres Therapeutics (MCRB) click here.